Towards the gene therapy of LAD-I immunodeficient patients

被引:0
|
作者
Almarza, E. [1 ,2 ,3 ]
Mesa-Nunez, C. [1 ,2 ,3 ]
Damian, C. [1 ,2 ,3 ]
Leon-Rico, D. [1 ,2 ,3 ]
Aldea, M. [1 ,2 ,3 ]
Carrascoso, C. [1 ,2 ,3 ]
Lozano, M. L. [1 ,2 ,3 ]
Guenechea, G. [1 ,2 ,3 ]
Thrasher, A. J. [4 ]
Bueren, J. A. [1 ,2 ,3 ]
机构
[1] Ctr Invest Energet Medioambientales & Tecnol CIEM, Div Haematopoiet Innovat Therapies, Madrid 28040, Spain
[2] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28040, Spain
[3] Fdn Jimenez Diaz IIS FJD UAM, Inst Invest Sanitaria, Adv Therapies Unit, Madrid, Spain
[4] Univ Coll London ICH UCL, Inst Child Hlth, Mol Immunol Unit, London WC1N 1EH, England
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
P010
引用
收藏
页码:A20 / A21
页数:2
相关论文
共 50 条
  • [21] Severe Leukocyte Adhesion Deficiency-I (LAD-I) Lentiviral-Mediated Ex-Vivo Gene Therapy: Ongoing Phase 1/2 Study Results
    Booth, Claire
    Sevilla, Julian
    Lopez, Maria Chitty
    Almarza, Elena
    Zubicaray, Josune
    Chetty, Kritika
    Moore, Theodore
    Bueren, Juan
    Schwartz, Jonathan
    Kohn, Donald
    CLINICAL IMMUNOLOGY, 2023, 250
  • [22] LENTIVIRAL-MEDIATED EX-VIVO GENE THERAPY FOR PEDIATRIC PATIENTS WITH SEVERE LEUKOCYTE ADHESION DEFICIENCY-I (LAD-I): INTERIM RESULTS FROM AN ONGOING PHASE 1/2 STUDY
    Kohn, Donald
    Sevilla, Julian
    Rao, Gayatri
    Lopez, Maria Chitty
    Almarza, Elena
    Terrazas, Dayna
    Zubicaray, Josune
    Gonzalez-Vicent, Marta
    Chetty, Kritika
    O'Toole, Grainne
    Xu-Bayford, Jinhua
    Nicoletti, Eileen
    Fernandes, Augustine
    Kuo, Caroline
    De Oliveira, Satiro
    Moore, Theodore B.
    Choi, Grace
    Zeini, Miriam
    Mesa-Nunez, Cristina
    Thrasher, Adrian
    Bueren, Juan
    Schwartz, Jonathan
    Booth, Claire
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 61 - 62
  • [23] Leukocyte Adhesion Deficiency-I (LAD-I): A comprehensive review of all published cases 1975-2017
    Kasbekar, Sanchali
    Almarza Novoa, Elena
    Thrasher, Adrian J.
    Kohn, Donald B.
    Sevilla, Julian
    Nguyen, Tony
    Burg, Cedric
    Bueren, Juan A.
    Schwartz, Jonathan D.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (03) : 380 - 381
  • [24] A Phase 1/2 Study of Lentiviral-mediated Ex-vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Initial Results from the First Treated Patient
    Kohn, Donald
    Rao, Gayatri
    Almarza, Elena
    Terrazas, Dayna
    Nicoletti, Eileen
    Fernandes, Augustine
    Kuo, Caroline
    De Oliveira, Satiro
    Moore, Theodore
    Law, Ken
    Beard, Brian
    Sevilla, Julian
    Mesa, Christina
    Bueren, Juan
    Schwartz, Jonathan
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (SUPPL 1) : S103 - S103
  • [25] A Phase 1/2 Study of Lentiviral-Mediated Ex-Vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Initial Results from the First Treated Patient
    Kohn, Donald
    Rao, Gayatri
    Almarza, Elena
    Terrazas, Dayna
    Nicoletti, Eileen
    Fernandes, Augustine
    Kuo, Caroline
    De Oliveira, Satiro
    Moore, Theodore
    Law, Ken
    Beard, Brian
    Sevilla, Julian
    Mesa-Nunez, Cristina
    Bueren, Juan
    Schwartz, Jonathan
    MOLECULAR THERAPY, 2020, 28 (04) : 56 - 57
  • [26] ALLOGENEIC STEM CELL TRANSPLANTATION RATES AND OUTCOMES IN SEVERE LEUKOCYTE ADHESION DEFICIENCY TYPE I (LAD-I): A SYSTEMATIC LITERATURE REVIEW
    Matos, J. E.
    Chitty-Lopez, M.
    Turner, S.
    Bailey, M.
    Schwartz, J. D.
    Rao, G.
    VALUE IN HEALTH, 2024, 27 (12)
  • [27] Discordance between clinical severity phenotype and CD11/CD18 expression in leukocyte adhesion deficiency type I (LAD-I)
    Poliak, Nina
    Abramson, Stuart
    Noroski, Lenora
    CLINICAL IMMUNOLOGY, 2008, 127 : S70 - S70
  • [29] TCR Gene Therapy of Melanoma: Towards a Phase I Clinical Trial
    Jorritsma, Annelies
    Gomez, Raquel
    Heemskerk, Bianca
    Nuijen, Bastiaan
    Haanen, John
    Schumacher, Ton
    MOLECULAR THERAPY, 2009, 17 : S219 - S219
  • [30] GENE-THERAPY IN PERIPHERAL-BLOOD LYMPHOCYTES AND BONE-MARROW FOR ADA(-) IMMUNODEFICIENT PATIENTS
    BORDIGNON, C
    NOTARANGELO, LD
    NOBILI, N
    FERRARI, G
    CASORATI, G
    PANINA, P
    MAZZOLARI, E
    MAGGIONI, D
    ROSSI, C
    SERVIDA, P
    UGAZIO, AG
    MAVILIO, F
    SCIENCE, 1995, 270 (5235) : 470 - 475